Nuvation Bio Inc.
Nuvation Bio Inc. (NUVB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NUVB · as of Jun 8, 2026
Key Statistics
Explore Nuvation Bio Inc. Data
nuvb stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 77.8%
The NUVB analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $13.00, representing +169.21% upside from the current price of $4.83.
Competitors & Peers
nuvb competitorsNUVB
ABCL
AUPH
CLDX
EWTX
GPCRStock Performance
Full HistoryAbout Nuvation Bio Inc.
Nuvation Bio Inc. a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhi…
what is nuvation bio inc. · nuvb stock overview · nuvation bio inc. company profile · who is nuvation bio inc. ceo · nuvb NYSE · nuvation bio inc. headquarters · nuvation bio inc. business segments
About Stock Overview & Key Data
Nuvation Bio Inc. (NUVB) is a Healthcare company in the Biotechnology industry, listed on NYSE since Aug 26, 2020. As of the latest trading session, NUVB stock price is $4.83, with a market capitalization of $1.7B. The stock has returned +92.63% over the past 12 months and -46.04% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Nuvation Bio Inc. stock is Buy, with an average 12-month price target of $13.00. In fiscal year 2025, Nuvation Bio Inc. reported revenue of $62.9M and net income of -$204.6M. For detailed data — including Nuvation Bio Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Nuvation Bio Inc. (NUVB) stock price is $4.83. The stock is traded on NYSE under the ticker symbol NUVB. The 52-week range is $1.57 – $9.75.